Page 2 - உலகளாவிய தலை தகவல்தொடர்புகள் பொது வாழ்க்கைத்தொழில்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உலகளாவிய தலை தகவல்தொடர்புகள் பொது வாழ்க்கைத்தொழில்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உலகளாவிய தலை தகவல்தொடர்புகள் பொது வாழ்க்கைத்தொழில்கள் Today - Breaking & Trending Today

Galapagos NV: Pipeline and capital for growth

Galapagos NV: Pipeline and capital for growth
Jyseleca approved for rheumatoid arthritis (RA) in Europe & Japan
Gilead decided not to pursue the RA indication in the U.S. as a result of Complete Response Letter (CRL) from the Food and Drug Administration (FDA)
Galapagos to assume commercialization of Jyseleca in Europe by the end of 2021, first sales achieved
Primary endpoint achieved in SELECTION Phase 3 trial in ulcerative colitis (UC) with Jyseleca, submitted for approval in UC in Europe
Positive topline results in PINTA Phase 2 trial with 1205 in idiopathic pulmonary fibrosis (IPF); no signal with 1972 in ROCCELLA Phase 2b trial in osteoarthritis (OA) ....

Region Flamande , United States , United Kingdom , Van Gijsel , Elizabeth Goodwin , Bart Filius , Carmen Vroonen , Anna Gibbins , European Commission , Drug Administration , Therapeutic Areas Communications , Gilead Sciences Inc , Global Head Communications Public Affairs , Exchange Commission , Japanese Ministry Of Health , Committee For Medicinal Products Human Use , Complete Response Letter , Belgian Government , Medicinal Products , Human Use , Annual Report , Japanese Ministry , Galapago Securities , Gilead Sciences , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,

Investegate |Galapagos NV Announcements | Galapagos NV: Pipeline and capital for growth

Investegate |Galapagos NV Announcements | Galapagos NV: Pipeline and capital for growth
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Region Flamande , United States , United Kingdom , Van Gijsel , Elizabeth Goodwin , Bart Filius , Carmen Vroonen , Anna Gibbins , European Commission , Drug Administration , Therapeutic Areas Communications , Gilead Sciences Inc , Global Head Communications Public Affairs , Exchange Commission , Japanese Ministry Of Health , Committee For Medicinal Products Human Use , Complete Response Letter , Belgian Government , Medicinal Products , Human Use , Publication Annual Report , Annual Shareholder , Japanese Ministry , Galapago Securities , Gilead Sciences , ஒன்றுபட்டது மாநிலங்களில் ,

The Capital Group holds 10.03% of Galapagos shares

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
The Capital Group holds 10.03% of Galapagos shares
Galapagos NVFebruary 9, 2021 GMT
Mechelen, Belgium; 9 February 2021; 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a new transparency notification from The Capital Group Companies, Inc.
Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on 5 February 2021 from The Capital Group Companies, Inc., that it holds 10.03% of the current 65,411,767 outstanding Galapagos shares. The Capital Group Companies, Inc. thus crossed above the 10% threshold of Galapagos’ voting rights by purchase of voting securities on 22 January 2021. The full transparency notice is available on the Galapagos website. ....

Region Flamande , United States , Van Gijsel , Elizabeth Goodwin , Carmen Vroonen , Anna Gibbins , Capital Group Companies Inc , Capital Bank Trust Company , Capital International , Capital Group International Inc , Capital Group , Capital International Inc , Capital Research Management Company , Therapeutic Areas Communications , Global Head Communications Public Affairs , Capital Group Companies , Capital Bank , Trust Company , Capital Research , Management Company , Capital Group International , Capital International Limited , American Depository Shares , Belgian Act , Globe Newswire , Western Europe ,

Gilead holds 25.54% of Galapagos shares

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Gilead holds 25.54% of Galapagos shares
Galapagos NVJanuary 11, 2021 GMT
Mechelen, Belgium; 11 January 2021; 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Gilead Sciences, Inc.
Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on 6 January 2021 from Gilead Sciences, Inc., who notified a change in the chain of intermediary companies through which Gilead holds its shares in Galapagos. The change in the chain of intermediary companies is the result of an internal reorganization as a result of which Gilead holds its shares in Galapagos as of 31 December 2020 through its direct subsidiary Gilead Biopharmaceutics US, LLC, which through Gilead Sciences Ireland UC controls Gilead Therapeutics A1 Unlimited Company, which in turn holds 16,707,477 of Galapagos’ voti ....

Region Flamande , Van Gijsel , Elizabeth Goodwin , Carmen Vroonen , Anna Gibbins , Unlimited Company , Gilead Biopharmaceutics , Gilead Sciences Ireland , Gilead Sciences Inc , Therapeutic Areas Communications , Global Head Communications Public Affairs , Gilead Sciences , Globe Newswire , Western Europe , எலிசபெத் குட்வின் , அண்ணா கிப்பின்ஸ் , வரம்பற்ற நிறுவனம் , கிலியட் அறிவியல் ஐயர்ல்யாஂட் , கிலியட் அறிவியல் இன்க் , சிகிச்சை பகுதிகள் தகவல்தொடர்புகள் , உலகளாவிய தலை தகவல்தொடர்புகள் பொது வாழ்க்கைத்தொழில்கள் , கிலியட் அறிவியல் , மேற்கு யூரோப் ,

Galapagos NV: Gilead holds 25.54% of Galapagos shares

Galapagos NV: Gilead holds 25.54% of Galapagos shares
Pursuant to Belgian transparency legislation
1, Galapagos received a transparency notification on 6 January 2021 from Gilead Sciences, Inc., who notified a change in the chain of intermediary companies through which Gilead holds its shares in Galapagos. The change in the chain of intermediary companies is the result of an internal reorganization as a result of which Gilead holds its shares in Galapagos as of 31 December 2020 through its direct subsidiary Gilead Biopharmaceutics US, LLC, which through Gilead Sciences Ireland UC controls Gilead Therapeutics A1 Unlimited Company, which in turn holds 16,707,477 of Galapagos voting rights, consisting of 16,707,477 shares (unchanged). Those 16,707,477 shares represent 25.54% of Galapagos currently outstanding 65,411,767 shares. ....

Region Flamande , Van Gijsel , Elizabeth Goodwin , Carmen Vroonen , Anna Gibbins , Unlimited Company , Gilead Biopharmaceutics , Gilead Sciences Ireland , Gilead Sciences Inc , Therapeutic Areas Communications , Global Head Communications Public Affairs , Gilead Sciences , எலிசபெத் குட்வின் , அண்ணா கிப்பின்ஸ் , வரம்பற்ற நிறுவனம் , கிலியட் அறிவியல் ஐயர்ல்யாஂட் , கிலியட் அறிவியல் இன்க் , சிகிச்சை பகுதிகள் தகவல்தொடர்புகள் , உலகளாவிய தலை தகவல்தொடர்புகள் பொது வாழ்க்கைத்தொழில்கள் , கிலியட் அறிவியல் ,